No Picture
News

Regulus Therapeutics Announces Closing of $34.6 Million Private Placement of Equity

SAN DIEGO: SAN DIEGO, Nov. 30, 2021 /PRNewswire/ — Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (the "Company" or "Regulus"), today announced the closing of its previously announced private placement of equity. The Company received gross proceeds of… Click here to view original post… […]

No Picture
San Diego Biotech Jobs

Senior Scientist Biochemistry and Biophysics – Quantum-Si – San Diego, CA

You will contribute scientific leadership and expertise to a multi-disciplinary team of scientists (including biologists, chemists, and computer scientists) who…From Quantum-Si – Tue, 30 Nov 2021 23:15:27 GMT – View all San Diego, CA jobsClick here to view original post… […]

No Picture
News

MEI Pharma Announces Proposed Public Offering of Common Stock

SAN DIEGO–(BUSINESS WIRE)–MEI Pharma, Inc. (Nasdaq: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, announced today that it plans to offer 17,500,000 shares of its common stock in an underwritten public offering. In connection with the offering, the Company intends to grant the underwriters a 30-day… Click here to view original post… […]

No Picture
News

Flu Virus Shells Could Improve Delivery of mRNA Into Cells

UC San Diego nanoengineers developed a new and potentially more effective way to deliver messenger RNA (mRNA) into cells. Their approach involves packing mRNA inside nanoparticles that mimic the flu virus—a naturally efficient vehicle for delivering genetic material such as RNA inside cells. Click here to view original post… […]

No Picture
News

BioCina officially opens full-service CDMO in Adelaide, Australia, including mRNA and pDNA cGMP manufacturing

SAN DIEGO and ADELAIDE, Australia: SAN DIEGO and ADELAIDE, Australia, Nov. 30, 2021 /PRNewswire/ — BioCina, a leading contract development and manufacturing organization (CDMO) specializing in process development and cGMP manufacturing of microbial-based therapeutics and mRNA vaccines announces the official opening of its new biologics manufacturing facility in Adelaide, Australia…. Click here to view original post… […]

No Picture
News

Which side is which?: How the brain perceives borders

LA JOLLA—In the classic “Rubin’s vase” optical illusion, you can see either an elaborate, curvy vase or two faces, noses nearly touching. At any given moment, which scene you perceive depends on whether your brain is viewing the central vase shape to be the foreground or background of the picture…. Click here to view original post… […]

No Picture
News

New High Fidelity CRISPR Cas9 Protein Reduces Off-target Effects for More Precise Genome Editing

CARLSBAD, Calif.: CARLSBAD, Calif., Nov. 30, 2021 /PRNewswire/ — For research applications requiring highly precise genome editing, including engineering CAR T cells and creating cellular models for disease discovery, the Invitrogen TrueCut HiFi Cas9 Protein* significantly minimizes off-target events while retaining maximum on-target editing efficiency. Thermo Fisher Scientific introduced the… Click here to view original post… […]

No Picture
News

Kintara Announces First International Site Activation in GCAR Phase 2/3 Clinical Trial for Glioblastoma

SAN DIEGO: SAN DIEGO, Nov. 30, 2021 /PRNewswire/ — Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced that the VAL-083 treatment arm in the Global Coalition for Adaptive Research (GCAR) registrational Phase 2/3 clinical… Click here to view original post… […]

No Picture
News

Evofem Biosciences Announces Successful Type C Meeting with FDA for STI Prevention Product Candidate

SAN DIEGO: SAN DIEGO, Nov. 30, 2021 /PRNewswire/ — Evofem Biosciences, Inc. (NASDAQ: EVFM) today reported a successful Type C meeting with the U.S. Food and Drug Administration in which agreement was reached on the preliminary submission strategy for EVO100 for two investigational indications: the prevention of urogenital chlamydia in… Click here to view original post… […]

No Picture
News

Lineage Reports Fourth Case of Retinal Tissue Restoration With OpRegen®

CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #LineageCellTherapeutics–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, announced today that restoration of retinal tissue was observed in a fourth patient enrolled in the Company’s Phase 1/2a clinical study of its lead product… Click here to view original post… […]

No Picture
News

ViaCyte Appoints Marty Lorenzo as General Counsel

SAN DIEGO: SAN DIEGO, Nov. 30, 2021 /PRNewswire/ — ViaCyte, Inc., a clinical-stage regenerative medicine company developing novel cell replacement therapies to address diseases with significant unmet needs, today announced the appointment of Marty Lorenzo as General Counsel. Mr. Lorenzo brings over 20 years in the legal profession leading corporate… Click here to view original post… […]

No Picture
News

After Big Pharma sparked interest in the US, Ablaze looks to bring radiopharmaceuticals overseas

Thanks in part to interest from Big Pharma players like Bayer and Novartis over the last decade, there’s been no shortage in cash for new companies looking to slay tumor cells with targeted radioisotopes. Now a transpacific upstart has hooked $75 million to bring the increasingly popular drugs to China…. Click here to view original post… […]

No Picture
News

ABM Therapeutics Receives IND Approval in China for BRAF Inhibitor ABM-1310

SAN DIEGO and SHANGHAI: SAN DIEGO and SHANGHAI, Nov. 30, 2021 /PRNewswire/ — ABM Therapeutics (ABM), a clinical-stage biopharmaceutical company with a focus on treating brain cancers and cancer metastases, today announced that its IND application for ABM-1310, a new-generation BRAF inhibitor, has been approved by the National Medical Products… Click here to view original post… […]

No Picture
San Diego Biotech Jobs

Proteomics Specialist – Sanford Burnham Prebys Medical Discovery Institute – La Jolla, CA

In this role, you will engage in implementation of proteomic projects in close collaboration with several research groups in the academia and industry.From Sanford Burnham Prebys Medical Discovery Institute – Tue, 30 Nov 2021 05:49:11 GMT – View all La… […]